The future of oxygen saturation monitoring with Rob Pupelis

Join me as I speak with Rob Pupelis, CEO of Spectros Medical
Devices, about the latest advancements in tissue oximetry and the
future of this medical technology. Rob is a leader in the
development of non-invasive sensing and remote monitoring in
healthcare, with a focus on shedding light on tissue health and
diseases related to vascular performance.





During our discussion, we cover a range of topics, including
Rob's background and involvement in this area of innovation, the
current problems and leverage points in the industry, and how
modern clinical practice informs future priorities regarding
tissue oximetry monitoring. We also delve into Rob's innovations
within tissue oximetry and how they might advance clinical and
critical care, as well as the results and themes that emerged in
the data when looking at tissue oxygenation.





Rob also unpacks the T-Stat Tissue Oximeter and explains why it
is both more sensitive and real-time in its readings. We explore
the main domains of medicine served by Spectros Medical Devices
and how they could impact critical care transfers and high acuity
transfers in pre-hospital care. Finally, Rob shares some
take-home points that he advocates in regard to tissue oximetry
monitoring. Don't miss out on this insightful conversation about
the future of medical technology. To find out more about the
T-Sat Tissue Oximeter see here:


https://www.spectros.com/#: